Safety Data Sheet: 1. Identification of The Substance/Preparation and of The Company Gasoline, Unleaded Carb
Safety Data Sheet: 1. Identification of The Substance/Preparation and of The Company Gasoline, Unleaded Carb
Manufacturer
Emergency Chemtrec: 1-800-424-9300
Tesoro Refining & Marketing Co.
Telephone Tesoro Call Center: 1-877-783-7676
19100 Ridgewood Parkway
San Antonio, TX 78259 E-mail address [email protected]
2. HAZARDS IDENTIFICATION
Classification
This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200)
Label elements
Danger
Appearance Clear liquid Physical State @20°C Liquid Odor Characteristic Hydroc
Other Information
May be harmful if swallowed.
3. COMPOSITION/INFORMATION ON INGREDIENTS
General Composition Statement Gasoline is a complex petroleum substance consisting of paraffinic hydrocarbons (normal
and branched chains), olefinic hydrocarbons, naphthenic hydrocarbons (cycloparaffins),
and aromatic hydrocarbons. Composition may contain additives and/or dyes which are not
considered hazardous at the concentration used.
Chemical Name CAS-No Percent
Gasoline 86290-81-5 10-100
Xylene 1330-20-7 10-30
Toluene 108-88-3 10-30
Ethanol; Ethyl alcohol 64-17-5 0-10
Trimethylbenzene 25551-13-7 1-5
Pentane 109-66-0 1-5
Naphthalene 91-20-3 1-5
Isopentane 78-78-4 1-5
Ethylbenzene 100-41-4 1-5
Cyclohexane 110-82-7 1-5
Butane 106-97-8 1-2
Benzene 71-43-2 0.1-1.3
n-Heptane 142-82-5 0.5-0.75
N-hexane 110-54-3 0.5-0.0075
General advice Show this safety data sheet to the doctor in attendance. Remove from exposure, lie down.
In case of accident or if you feel unwell, seek medical advice immediately. When
symptoms persist or in all cases of doubt, seek medical advice. Never give anything by
mouth to an unconscious person. Take off all contaminated clothing immediately and
thoroughly wash material from skin. Immediate medical attention is required.
Inhalation Remove to fresh air. Aspiration into lungs can produce severe lung damage. If breathing
has stopped, give artificial respiration. Get medical attention immediately. Avoid direct
contact with skin. Use barrier to give mouth-to-mouth resuscitation. If breathing is
difficult, (trained personnel should) give oxygen. Get immediate medical advice/attention.
Delayed pulmonary edema may occur. Immediate medical attention is required. Do not
use
mouth-to-mouth method if victim ingested or inhaled the substance; give artificial respiration
with the aid of a pocket mask equipped with a one-way valve or other proper respiratory
medical device.
Eye contact Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes.
Keep eye wide open while rinsing. Do not rub affected area. Remove contact lenses, if
present and easy to do. Continue rinsing. Get medical attention if irritation develops and
persists.
Skin contact Wash off immediately with soap and plenty of water while removing all
contaminated clothes and shoes. If symptoms persist, call a physician.
Ingestion Do NOT induce vomiting. Clean mouth with water and drink afterwards plenty of water.
Never give anything by mouth to an unconscious person. ASPIRATION HAZARD IF
SWALLOWED - CAN ENTER LUNGS AND CAUSE DAMAGE. If vomiting occurs
spontaneously, keep head below hips to prevent aspiration. Get immediate medical
advice/attention.
Self-protection of the first aider Remove all sources of ignition. Ensure that medical personnel are aware of the material(s)
involved, take precautions to protect themselves and prevent spread of contamination. Use
personal protective equipment as required. See section 8 for more information. Wear
personal protective clothing (see section 8). Avoid contact with skin, eyes or clothing. Do
not use mouth-to-mouth method if victim ingested or inhaled the substance; give artificial
respiration with the aid of a pocket mask equipped with a one-way valve or other proper
respiratory medical device. Do not breathe vapor or mist.
Symptoms Difficulty in breathing. Coughing and/ or wheezing. Dizziness. Inhalation of high vapor
concentrations may cause symptoms like headache, dizziness, tiredness, nausea
and
vomiting.
Note to physicians Because of the danger of aspiration, emesis or gastric lavage should not be employed
unless the risk is justified by the presence of additional toxic substances.
5. FIRE-FIGHTING MEASURES
Suitable Extinguishing Media Dry chemical. Carbon dioxide (CO2). Water spray. Alcohol resistant foam.
Small Fire Any extinguisher suitable for Class B fires, dry chemical, CO2, foam (AFFF/ATC), or
water spray can be used.
Large Fire Water spray, fog or alcohol-resistant foam. CAUTION: Use of water spray when fighting fire
may be inefficient. Cool containers with flooding quantities of water until well after fire is
out.
Unsuitable extinguishing media CAUTION: Use of water spray when fighting fire may be inefficient.
Hazardous combustion products Smoke, CO, and other products of incomplete combustion.
Explosion data
Sensitivity to Mechanical Impact None.
Sensitivity to Static Discharge Yes.
Further information ALWAYS stay away from tanks engulfed in fire. Fight fire from maximum distance or use
unmanned hose holders or monitor nozzles. Withdraw immediately in case of rising sound
from venting safety devices or discoloration of tank. Do not direct water at source of leak or
safety devices; icing may occur. Cool containers with flooding quantities of water until well
after fire is out. Do not allow run-off from fire-fighting to enter drains or water courses.
Personal precautions Evacuate personnel to safe areas. Use personal protective equipment as required. See
section 8 for more information. Avoid contact with skin, eyes or clothing. Ensure adequate
ventilation. Keep people away from and upwind of spill/leak. ELIMINATE all ignition sources
(no smoking, flares, sparks or flames in immediate area). Pay attention to flashback. Take
precautionary measures against static discharges. All equipment used when handling the
product must be grounded. Do not touch or walk through spilled material. Do not breathe
vapor or mist.
Other Information Ventilate the area. Refer to protective measures listed in Sections 7 and 8.
Environmental precautions
Environmental precautions Refer to protective measures listed in Sections 7 and 8. Prevent further leakage or
spillage if safe to do so. Prevent product from entering drains.
Methods for cleaning up Take precautionary measures against static discharges. Dam up. Soak up with inert
absorbent material. Pick up and transfer to properly labeled containers.
Prevention of secondary hazards Clean contaminated objects and areas thoroughly observing environmental regulations.
Advice on safe handling Use personal protection equipment. Avoid contact with skin and eyes. Keep away from
heat/sparks/open flames/hot surfaces. - No smoking. Use grounding and bonding
connection when transferring this material to prevent static discharge, fire or explosion. Use
spark-proof tools and explosion-proof equipment. Keep in an area equipped with sprinklers.
Use according to package label instructions. Handle in accordance with good industrial
hygiene and safety practice. Avoid contact with skin, eyes or clothing. Do not eat, drink or
smoke when using this product. Remove contaminated clothing and shoes. Take off
contaminated clothing and wash before reuse. Do not breathe vapor or mist. In case of
insufficient ventilation, wear suitable respiratory equipment. Handle product only in closed
system or provide appropriate exhaust ventilation.
Storage Conditions Keep containers tightly closed in a dry, cool and well-ventilated place. Keep away from
heat, sparks, flame and other sources of ignition (i.e., pilot lights, electric motors and static
electricity). Keep in properly labeled containers. Do not store near combustible materials.
Keep in an area equipped with sprinklers. Store in accordance with the particular national
regulations. Store in accordance with local regulations. Store locked up. Keep out of the
reach of children. Store away from other materials.
NOTE: Limits shown for guidance only. For additional information, OSHA’s 1989 air contaminants standard exposure limits
provided even though the limits were vacated in 1992. State, local or other agencies or advisory groups may have established
more stringent limits. Follow applicable regulations.
Skin and body protection Wear suitable protective clothing. Long sleeved clothing. Chemical resistant apron.
Antistatic boots.
Respiratory protection When workers are facing concentrations above the exposure limit they must use
appropriate certified respirators. Use a NIOSH approved respirator when there is a potential
for airborne concentrations to exceed occupational exposure limits. Refer to OSHA 29 CFR
1910.134, ANSI Z88.2, NIOSH Respirator Decision Logic, and the respirator manufacturer
for additional guidance on respiratory protection selection. A Self-Contained Breathing
Apparatus (SCBA) should be used for fire fighting. Use a NIOSH approved
positive-pressure supplied air respirator if there is a potential for uncontrolled release,
exposure levels are unknown, in oxygen deficient (less than 19.5% oxygen), or any other
circumstance where an air-purifying respirator may not provide adequate protection.
General hygiene considerations Do not eat, drink or smoke when using this product. Contaminated work clothing should not
be allowed out of the workplace. Regular cleaning of equipment, work area and clothing is
recommended. Wash hands before breaks and immediately after handling the product.
Avoid contact with skin, eyes or clothing. Wear suitable gloves and eye/face protection. Do
not breathe vapor or mist. Remove and wash contaminated clothing and gloves, including
the inside, before re-use.
Inhalation Specific test data for the substance or mixture is not available. Aspiration into lungs can
produce severe lung damage. May cause pulmonary edema. Pulmonary edema can be
fatal. May cause irritation of respiratory tract. Toxic by inhalation. (based on
components). May cause drowsiness or dizziness by inhalation.
Eye contact Specific test data for the substance or mixture is not available. Irritating to eyes. (based
on components).
Skin contact Repeated exposure may cause skin dryness or cracking. Specific test data for the
substance or mixture is not available. Causes skin irritation. (based on
components).
Ingestion Specific test data for the substance or mixture is not available. Potential for aspiration if
swallowed. May cause lung damage if swallowed. Aspiration may cause pulmonary
edema and pneumonitis. May be fatal if swallowed and enters airways. Ingestion may
cause gastrointestinal irritation, nausea, vomiting and diarrhea.
Symptoms Difficulty in breathing. Coughing and/ or wheezing. Dizziness. Redness. May cause
redness and tearing of the eyes. Inhalation of high vapor concentrations may cause
symptoms like headache, dizziness, tiredness, nausea and vomiting.
Acute toxicity
The following values are calculated based on chapter 3.1 of the GHS document .
ATEmix (oral) 2,558.00 mg/kg
ATEmix (dermal) 1,126.00 mg/kg
ATEmix (inhalation-gas) 13,840,416.38
ATEmix (inhalation-dust/mist) 1.00 mg/l
Component Information
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Chemical Name
Xylene Mixed xylenes can cause skin, eye, and respiratory irritation. Both short- and long-term
repeated exposures to high enough levels in humans have resulted in a variety of adverse
nervous system effects that include headache, mental confusion, narcosis, equilibrium,
impaired short-term memory, dizziness and tremors. Studies in laboratory animals indicate
that xylene can cause changes in the liver and harmful effects on the kidneys, lungs, heart,
and nervous system as well as hearing loss. The relevance of these observations to
humans is not clear at this time. In general, developmental studies in animals reported
adverse fetal effects only at concentrations that caused maternal toxicity. The relevance of
these observations to humans is unclear at this time. The available data from in vitro and in
vivo studies suggest that xylenes are not mutagenic and do not produce chromosomal
abnormalities. Furthermore, rats exposed up to 500 mg/kg bw and mice exposed up to
1000 mg/kg bw mixed xylenes for 103 weeks showed no treatment-related increases in
any tumor type. IARC has determined that the carcinogenicity of xylenes is not classifiable
(Group 3).
Ethanol; Ethyl alcohol Short term (acute) direct contact with liquid ethanol to eyes or skin may cause eye irritation
or dry skin. Acute exposure to ethanol by inhalation of high concentrations of vapor may
cause irritation of the eyes and respiratory tract. Inhalation studies show that ethanol
overexposure can produce incoordination and narcosis (drowsiness or unconsciousness)
and ethanol targets the central nervous system. Long term or repeated to high enough
levels by skin contact with liquid ethanol can result in defatting of the skin and dermatitis.
There is little evidence to suggest that ethanol is genotoxic; it may have a very limited
capacity to induce genetic changes in vivo at very high doses achievable in humans by
deliberate oral ingestion. Evidence of the carcinogenicity of ethanol in humans is confined
to studies assessing the impact of alcoholic beverage consumption. IARC has classified
ethanol in alcoholic beverages as carcinogenic to humans (Group 1). Studies in laboratory
rats indicate no fertility or developmental effects at inhalation exposures up to 16000 ppm.
The potential for reproductive and developmental toxicity exists in humans from deliberate
consumption of ethanol. Additional severe acute and chronic effects can be expected with
ethanol overconsumption, however, ingestion is not expected to be a significant route of
exposure in an occupational setting.
Trimethylbenzene Trimethylbenzenes are a commercially available mixture of three separate isomers: 1,2,3-,
1,2,4-, 1,3,5-trimethylbenzene. Overexposure to trimethylbenzenes is known to result in
irritation of the eyes, skin, and respiratory tract in humans and animals. Acute (short-term)
and chronic (long-term) inhalation exposure to high enough levels of trimethylbenzenes has
been shown to result in neurological effects in humans and animals. There is limited
evidence that overexposure by inhalation of trimethylbenzenes can result in hematological
effects such as alterations in blood clotting and anemia in humans. Animal studies have
also found evidence that inhalation exposure to trimethylbenzenes can result in
hematological effects. No human studies have investigated the reproductive or
developmental effects of trimethylbenzenes. Reproductive and developmental effects in
animals exposed to trimethylbenzene has been reported.
Pentane Pentane may be fatal if it is swallowed and enters the airway. If inhaled, short-term (acute)
overexposure can cause drowsiness, disorientation, other narcotic effects, and possibly
death. Acute exposure to n-pentane by inhalation and ingestion results in low toxicity in
animal studies. Exposure can cause irritation to eyes, skin (including dermatitis), and
nose. Sensitization has not been reported. Exposure to high enough levels may also affect
the central nervous system (CNS).
Naphthalene Acute (short term) exposure to large amounts of naphthalene may damage or destroy red
blood cells, a condition termed hemolytic anemia. Symptoms of hemolytic anemia include
fatigue, lack of appetite, restlessness, and pale skin. Acute inhalation or oral exposure to
large amounts of naphthalene may also cause nausea, vomiting, diarrhea, blood in the
urine, and a yellow color to the skin. Ingestion may result in death. Chronic (long term)
exposure in rats and mice can lead to irritation and inflammation of their nose and lungs;
nasal hyperplasia and metaplasia in respiratory and olfactory epithelium has been reported
in studies in mice. Exposure to high enough levels may have effects on the blood, resulting
in chronic hemolytic anemia, and effects on the eyes, resulting in the development of
cataracts. Cancer from naphthalene exposure has been observed in animals, but not
humans. IARC has classified naphthalene as possibly carcinogenic to humans (Group 2B),
and the ECHA C&L Inventory reports that naphthalene is suspected of causing cancer
(Carc. 2).
Ethylbenzene Ethylbenzene may be fatal if it is swallowed and enters the airways. Short term (acute)
exposure to ethylbenzene can cause eye, skin, and throat irritation. It may have effects on
the central nervous system including dizziness, and at very high exposure, lowering on
consciousness. Long-term exposures orally and by inhalation have been shown to cause
damage to the inner ear and hearing in animals. Long term or repeated exposure to high
enough levels of ethylbenzene may have effects on the kidneys and liver, resulting in
impaired functions, and repeated contact with skin may cause dryness and cracking.
Animal studies indicate some evidence of adverse effects on the liver, kidney, thyroid, and
pituitary gland. In a 2-year inhalation study in mice and rats, the animals were exposed to
0, 75, 250, and 750 ppm ethylbenzene 6 hours/day, 5 days/week. Renal effects were
observed in male rats (renal tubule hyperplasia) and female rats (renal tubule adenoma
and adenoma or carcinoma) exposed to 750 ppm. The incidence of adenoma in the testes
of males was significantly greater than in the control group and exceeded the historical
control range for inhalation studies. The incidences of alveolar/bronchiolar adenoma was
increased in males and the incidence of hepatocellular adenoma was increased in females.
IARC has classified ethylbenzene as possibly carcinogenic to humans (Group 2B). Studies
do not provide conclusive evidence of reproductive effects. In one study, developmental
effects were reported in animals but only at very high doses (≥1000 ppm) that are likely to
be toxic to the mother. The relevance of these findings to humans is not clear at this time.
Cyclohexane Cyclohexane may be fatal if it is swallowed and enters the airways. Cyclohexane has low
acute oral, dermal, and inhalation toxicity. Acute (short-term) overexposure can irritate and
burn the eyes, irritate the nose and throat, and cause coughing, wheezing, headache,
dizziness, nausea, vomiting, lightheadedness, drowsiness, and unconciousness at high
concentrations. Chronic inhalation exposure caused maternal toxicity and developmental
effects in rats. At high enough levels, repeated or prolonged contact with skin may cause
dermatitis.
Butane If inhaled, short-term overexposure to hydrocarbon gases may cause rapid suffocation.
Inhalation of butane at very high concentrations can cause drowsiness, narcosis, axphyxia,
and cardiac arrhythmia; butane affects the central nervous system (CNS). As gases, the
primary route of exposure is inhalation; compressed gases may exhibit additional hazards.
In animal studies, 2-Butene was the most toxic of the C1-4 hydrocarbon gas (C1-4 HCs)
evaluated for its short term (acute) toxicity when inhaled for four hours at 10,000 ppm (23.1
g/m3); no fatalities were observed, and no LC50 value was established. Repeated dose
toxicity has been observed in combination with testing for reproductive and developmental
toxicity; the lowest does at which adverse effects were observed (LOAEL) following
repeated dose reported to be 5,000 ppm. Adverse effects included lowered body weight,
though some changes in blood chemistry were also reported. C1-4 HCs were not
mutagenic in several test systems using bacteria or mammalian cells, nor were they
mutagenic in animal studies. No adverse developmental effects were reported for the
highest dose tested (NOAEL ≥ 5,000 ppm). Reproductive toxicity was reported for
isobutene (LOAEL = 9,000 ppm) as reduced fertility in females and pregnancy loss; caution
should be used in interpreting the results of this study due to the small number of animals
tested. The carcinogenicity of individual petroleum streams varies due to factors such as
source and processing; IARC and ECHA C&L Inventory reports individually on the
carcinogenicity of these substances.
Benzene Benzene exposure may occur through inhalation, ingestion, skin absorption or eye contact.
Benzene exposure can cause skin, eye and respiratory irritation. The most characteristic
systemic effect resulting from high enough intermediate and chronic benzene exposure is
arrested development of blood cells. Studies have linked overexposure to benzene to
many hematological effects including aplastic anemia, pancytopenia, leukopenia, and
myelodysplastic syndrome. In vivo and in vitro data from both humans and animals show
that benzene and/or its metabolites are genotoxic. Studies in animals provide supporting
evidence for the carcinogenicity of inhaled benzene. Epidemiological studies have reported
a causal relationship between occupational benzene exposures and acute myelogenous
leukemia. Some studies suggest associations between benzene exposure and
non-Hodgkin’s lymphoma, multiple myeloma, and other cancers. Benzene has been
classified as carcinogenic to humans (Group 1) by IARC, and the ECHA C&L Inventory
states it may cause cancer (Carc. 1B). IARC concluded that benzene causes acute myeloid
leukemia and a positive association has been observed for acute lymphatic leukemia,
chronic lymphatic leukemia, non-hodgkin lymphoma, and multiple myeloma. Human studies
suggest that female fertility and menstrual cycles were effected by benzene exposure;
however, due to uncertainties in exposure and limited data the studies were considered
inconclusive. Developmental effects have been observed in animals including persistent
hematopoietic anomalies. It has been suggested that the reported benzene fetotoxicity of
decreased weight and skeletal variants is a function of maternal toxicity.
N-hexane N-Hexane may be fatal if it is swallowed and enters the airways. Acute (short-term) dermal
overexposure can cause skin and eye irritation in humans. Acute inhalation and oral
exposures have caused systemic effects such as decreased body weight and respiratory
effects, as well as reproductive and developmental effects in animals. Respiratory effects
may include nose, throat, and lung irritation, coughing, wheezing, and shortness of breath.
Acute overexposures may also cause headache, nausea, vomiting, dizziness,
lightheadedness, loss of consciousness, coma, and death in human. Intermediate duration
inhalation and oral exposures to relatively high concentrations (400-3,000 ppm) of n-
hexane have led to nerve damage, paralysis, and/or deaths in rats. N-hexane may damage
male reproductive glands. Intermediate-duration inhalation and oral exposure to high levels
(1,000-10,000 ppm; 4,000 mg/kg/day) of n-hexane damages sperm-forming cells and
testicles in rats. Chronic (long-term) inhalation of large amounts of n-hexane causes nerve
damage and paralysis of the arms and legs in humans. Dermal effects, such as a skin rash,
dryness, or redness can also occur following chronic overexposure. Chronic duration
inhalation exposures in animals are not available.
Skin Corrosion/Irritation Category Classification based on data available for ingredients. Irritating to skin.
No information available.
Germ cell mutagenicity Classification based on data available for ingredients. Contains a known or suspected
mutagen. The table below indicates ingredients above the cut-off threshold considered as
relevant which are listed as mutagenic.
Carcinogenicity Classification based on data available for ingredients. Contains a known or suspected
carcinogen.
The table below indicates whether each agency has listed any ingredient as a carcinogen.
Chemical Name ACGIH IARC NTP OSHA
Gasoline A3 Group 2B - X
86290-81-
5
Xylene - Group 3 - -
1330-20-
7
Toluene - Group 3 - -
108-88-3
Ethanol; Ethyl alcohol A3 Group 1 Known X
64-17-5
Naphthalen A3 Group 2B Reasonably Anticipated X
e 91-20-3
Ethylbenzen A3 Group 2B - X
e 100-41-4
Benzene A1 Group 1 Known X
71-43-2
IARC (International Agency for Research on Cancer)
Group 3 - Not Classifiable as to Carcinogenicity in Humans
Reproductive toxicity Classification based on data available for ingredients. Contains a known or suspected
reproductive toxin. The table below indicates ingredients above the cut-off threshold
considered as relevant which are listed as reproductive toxins.
Target organ effects liver, kidney, Respiratory system, Eyes, Skin, Central nervous system, blood, bone marrow,
Reproductive System.
Waste from residues/unused Should not be released into the environment. Dispose of in accordance with local
products regulations. Dispose of waste in accordance with environmental legislation.
Contaminated packaging Empty containers pose a potential fire and explosion hazard. Do not cut, puncture of weld
containers.
Chemical Name RCRA RCRA - Basis for Listing RCRA - D Series Wastes RCRA - U Series Wastes
Xylene - Included in waste stream: - U239
1330-20- F039
7
Toluene U220 Included in waste - U220
108-88-3 streams: F005, F024,
F025, F039, K015, K036,
K037, K149, K151
Naphthalen U165 Included in waste - U165
e 91-20-3 streams: F024, F025,
F034, F039, K001, K035,
K060, K087, K145
Ethylbenzen - Included in waste stream: - -
e 100-41-4 F039
Cyclohexane - - - U056
110-82-7
Benzene U019 Included in waste 0.5 mg/L regulatory level U019
71-43-2 streams: F005, F024,
F025, F037, F038, F039,
K085, K104, K105, K141,
K142, K143, K144, K145,
K147, K151, K159, K169,
K171, K172
Chemical Name RCRA - Halogenated RCRA - P Series Wastes RCRA - F Series Wastes RCRA - K Series Wastes
Organic Compounds
Toluene - - Toxic waste -
108-88-3 waste number F025
Waste description:
Condensed light ends,
spent filters and filter
aids, and spent desiccant
wastes from the
production of certain
chlorinated aliphatic
hydrocarbons, by free
radical catalyzed
processes. These
chlorinated aliphatic
hydrocarbons are those
having carbon chain
lengths ranging from one
to and including five, with
varying amounts and
positions of chlorine
substitution.
Naphthalene - - Toxic waste -
91-20-3 waste number F025
Waste description:
Condensed light ends,
spent filters and filter
aids, and spent desiccant
wastes from the
production of certain
chlorinated aliphatic
hydrocarbons, by free
radical catalyzed
processes. These
chlorinated aliphatic
hydrocarbons are those
having carbon chain
lengths ranging from one
to and including five, with
varying amounts and
positions of chlorine
substitution.
California Hazardous Waste Status This product contains one or more substances that are listed with the State of California as
a hazardous waste.
Legend:
TSCA - United States Toxic Substances Control Act Section 8(b) Inventory
DSL/NDSL - Canadian Domestic Substances List/Non-Domestic Substances List
ENCS - Japan Existing and New Chemical Substances
IECSC - China Inventory of Existing Chemical Substances
KECL - Korean Existing and Evaluated Chemical Substances
PICCS - Philippines Inventory of Chemicals and Chemical Substances
AICS - Australian Inventory of Chemical Substances
US Federal Regulations
SARA 313
Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 (SARA). This product does not contain any
chemicals which are subject to the reporting requirements of the Act and Title 40 of the Code of Federal Regulations, Part 372.
Chemical Name CWA - Reportable CWA - Toxic Pollutants CWA - Priority Pollutants CWA - Hazardous
Quantities Substances
Xylene 100 lb - - X
1330-20-
7
Toluene 1000 lb X X X
108-88-3
Naphthalen 100 lb X X X
e 91-20-3
Ethylbenzen 1000 lb X X X
e 100-41-4
Cyclohexane 1000 lb - - X
110-82-7
Benzene 10 lb X X X
71-43-2
CERCLA
The CERCLA definition of hazardous substances contains a “petroleum exclusion” clause which exempts crude oil, fractions of
crude oil, and products (both finished and intermediate) from the crude oil refining process and any indigenous components of
such from the CERCLA Section 103 reporting requirements. However, other federal reporting requirements, including SARA
Section 304, as well as the Clean Water Act may still apply.
US State Regulations
California Proposition 65
This product contains the following Proposition 65 chemicals.
US State Regulations
Disclaimer
Tesoro Companies, Inc. (Tesoro) provides the information on this Safety Data Sheet (SDS) in order to meet its obligations
under 29 CFR 1910.1200, and does not hereby make any guarantee of product specifications or suitability for any
particular purpose. Tesoro does not assume any liability arising out of the use of Tesoro’s product or the use of
information provided on this SDS. The end user of the product has the responsibility for evaluating the adequacy of the
data under the conditions of use, determining the safety, toxicity and suitability of the product under these conditions,
and obtaining additional or clarifying information where uncertainty exists. No guarantee expressed or implied is made as
to the effects of such use, the results to be obtained, or the safety and toxicity of the product in any specific application.
Furthermore, the information herein is not represented as absolutely complete, since it is not practicable to provide all
relevant information in the format of this document, since additional information may be necessary under exceptional
conditions of use, and since Tesoro prepared this SDS based on information available on the date of its publication.
112, 130, 1171, 1373, 1421, 1430, 1440, 1540, 1734, 1740, 1177, 1178, 1179, 1237, 1238, 1239, 1322, 1324, 1332, 1335, 1502,
1503, 1504, 1505, 1500, 1397, 1399, 1406, 1438, 1439
End of Safety Data Sheet